Medtronic plc (MDT) operating KPIs
MDTNYSEElectromedical & Electrotherapeutic ApparatusFiscal year ends April 24
Financials through Q1 FY2027, quarter ended Jul 31, 2026Last filing: 10-Q on Sep 3, 2026Score 19/303% below fair value
$96.54−0.57 (-0.59%)
Close on Oct 30, 2026Market cap $123.49BP/E 23.7Yield 2.94%
Medtronic miniMed — GAAP R&D Expense ($M) ($M)
Annual figures from Medtronic's filings and investor materials
Latest, FY2026
448
Period ended Apr 30, 2026
Change on a year earlier
+2.8%
436 in FY2025
History
3 years
Since FY2024
Sources
2
Documents cited below
Annual history
Hover a value to see the sentence it was read from; calculated values show their formula
| Period | Ended | MiniMed — GAAP R&D Expense ($M) ($M) | Year on year | Source |
|---|---|---|---|---|
| FY2026 | Apr 30, 2026 | 448 | +2.8% | MiniMed Group FY2026 Q4 Earnings Presentation ↗ |
| FY2025 | Apr 30, 2025 | 436 | -0.2% | MiniMed Group FY2026 Q4 Earnings Presentation ↗ |
| FY2024 | Apr 30, 2024 | 437 | – | MiniMed Group (MMED) 10-K — 10k_FY2026 (filed 2026-06-29) ↗ |
Cite this data
StockData. (2026). Medtronic MiniMed — GAAP R&D Expense ($M) ($M), annual FY2024–FY2026 [Data set]. Compiled from Medtronic SEC filings and investor materials. https://stockdatahq.com/stocks/mdt/kpis/mmed-sub-gaap-rd
See every metric in the Medtronic KPI table. Data updated Oct 31, 2026.